TrialSignal
Clinical trial intelligence report
The Therapeutic Effect and Quality of Life After Local Injection of Steroid VS. Glucose 5% for Carpal Tunnel Syndrome : Double-blinded Clinical Trial
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT05496764-Jul 28, 2026
NCT ID
NCT05496764
Status
UNKNOWN
Phase
PHASE4
Sponsor
Assiut University
Executive brief
Investment-Ready Snapshot
The Therapeutic Effect and Quality of Life After Local Injection of Steroid VS. Glucose 5% for Carpal Tunnel Syndrome : Double-blinded Clinical Trial is a PHASE4 clinical asset sponsored by Assiut University in Carpal Tunnel Syndrome. SEO and diligence focus: Dexamethasone, Glucose Injection, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT05496764
Indication
Carpal Tunnel Syndrome
Modality
small molecule
Target
Dexamethasone, Glucose Injection
Intervention
Dexamethasone, Glucose Injection
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.